Publications
Research at the Leibniz Institute for Immunology focuses on the development of pioneering immune-cell therapies targeting cancer, autoimmune diseases, and chronic inflammation. While developments in this field are highly relevant within the medical community, they are also of great interest to the wider general public. The LIT has a comprehensive archive of international articles, publications, lectures, and online resources aimed at a variety of audiences. So, whoever you are, if you do not find what you are looking for, please do not hesitate to contact us.
Duque-Afonso J, Finke J, Ngoya M, Galimard JE, Schetelig J, Eder M, Rosler W, Bug G, Neubauer A, Edinger M, Wulf GG, Jindra P, Einsele H, Stelljes M, Selleslag D, Wagner-Drouet EM, Bunjes D, Spyridonidis A, Brissot E, Nagler A, Ciceri F, Mohty M. Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone Marrow Transplant. 2025 Mar. 60:373-379. doi:10.1038/s41409-024-02499-6. PMID: 39702670
Baldwin JG, Silveira CRF, Gattinoni L. Restoring the supply lines: removing roadblocks to fatty acid uptake enhances T cell-driven cancer fight. Signal Transduct Target Ther. 2025 Feb 14. 10:53. doi:10.1038/s41392-025-02151-9. PMID: 39948077
Staudt S, Nikolka F, Perl M, Franz J, Leblay N, Yuan XK, Larrayoz M, Lozano T, Warmuth L, Fante MA, Skorpskaite A, Fei T, Bromberg M, San Martin-Uriz P, Rodriguez-Madoz JR, Ziegler-Martin K, Adil-Gholam N, Benz P, Tran Huu P, Freitag F, Riester Z, Stein-Thoeringer C, Schmitt M, Kleigrewe K, Weber J et al. Metabolization of microbial postbiotic pentanoate drives anti-cancer CAR T cells. bioRxiv. 2025 Feb 4. doi:10.1101/2024.08.19.608538. PMID: 39314273
Guetter S, Fan K, Poeck H. Cancer cell reprogramming: turning the enemy into an ally. Signal Transduct Target Ther. 2025 Jan 17. 10:13. doi:10.1038/s41392-024-02102-w. PMID: 39820487
Kessel C, Rossig C, Abken H. Weal and woe of interleukin-18 in the T cell therapy of cancer. J Immunother Cancer. 2025 Jan 14. 13doi:10.1136/jitc-2024-010545. PMID: 39809514
Westermann L, Diergaarde B, Heidegger S, Poeck H, Szczepanski MJ, Reichert TE, Spoerl S, Whiteside TL, Spoerl S, Ludwig N. Expression of vesiculation-related genes is associated with a tumor-promoting microenvironment: a pan-cancer analysis. Clin Transl Oncol. 2025 Jan 8. doi:10.1007/s12094-024-03796-8. PMID: 39776398
Kessel C, Rossig C, Abken H. Weal and woe of interleukin-18 in the T cell therapy of cancer. J Immunother Cancer. 2025 Jan 14. 13doi:10.1136/jitc-2024-010545. PMID: 39809514
Safi S, Krzykalla J, Hoffmann H, Benner A, Bischoff H, Eichhorn M, Kriegsmann M, Poschke I, Stogbauer F, Umansky L, Mogler C, Weichert W, Winter H, Beckhove P, Muley T. Low tumor interleukin-1beta expression predicts a limited effect of adjuvant platinum-based chemotherapy for patients with completely resected lung adenocarcinoma: An identification and validation study. Pulmonology. 2025 Dec 31. 31:2416803. doi:10.1016/j.pulmoe.2024.03.003. PMID: 38614857
Kupke P, Yang Zhou J, Glehr G, Riquelme P, Scheibert L, Adenugba A, Schlitt HJ, Geissler EK, Werner JM, Hutchinson JA. Proteolytic shedding of CD46 from human hepatocytes indicates liver stress. Heliyon. 2024 Dec 15. 10:e40841. doi:10.1016/j.heliyon.2024.e40841. PMID: 39698100
Arslan A, Labuhn S, Sala E, Ringhoffer M, Schetelig J, Schroder T, Bug G, Franke GN, Stelljes M, Dreger P, Zeiser R, Teschner D, Bethge W, Eder M, Edinger M, Amann EM, Neuchel C, Schmid-Moglich A, Schmeller S, Beyersmann J, Schrezenmeier H, Mytilineos J, Kroger N, Furst D. Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany. Blood Adv. 2024 Dec 10. 8:6104-6113. doi:10.1182/bloodadvances.2024013719. PMID: 39368803